Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report

Affiliations

• ¹ University of North Carolina School of Medicine, Chapel Hill, NC.
• ² Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ³ Department of Pathology and Lab Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ⁴ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ⁵ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ⁶ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ⁷ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: [email protected].